United Medix Labs, Helsinki, Finland

United Medix Laboratories is a clinical central laboratory and analyses approx. 4 million tests annually within all branches of clinical laboratory analyses. Within the field of therapeutic drug monitoring the main aim is to provide drug level and anti-drug antibody analyses to help clinicians in personalizing use of biologicals.

Diseases Researched:

The main diseases for which therapeutic drug monitoring are:

  • Crohn’s disease
  • Ulcerative colitis
  • Rheumatoid arthritis
  • Spondyloarthropathies
  • Psoriatic arthritis
  • Psoriasis

Performed Tests:

Drug levels:

  • Measures infliximab, adalimumab, golimumab, etanercept, certolizumab pegol, vedolizumab, ustekinumab, and tocilizumab with ELISA.

ADA titres:

  • Measures ADA against infliximab, adalimumab, golimumab, etanercept, certolizumab pegol, vedolizumab, ustekinumab, and tocilizumab with radioimmunoassay (RIA) and Mass Spectrometry

Website link: www.yml.fi (Finnish and English), www.unitedmedixlabs.com (English)